INTRODUCTION
Cyclic fluctuations in heart rate during sinus rhythm vary in response to a range of physiological regulatory systems. These fluctuations have been utilized to study autonomic regulation of human cardiovascular physiology. (2, 12, 28) The origin of variations in the sinus interval is not fully explained, but appears to be predominantly determined by interactions between the autonomic nervous system, hormonal efferent systems and cardiac pacemaker cells. (12, 28) Analysis of heart rate variability by spectral methods (frequency domain analysis) is widely used to study autonomic tone and variations thereof. Although variations in beat-to-beat intervals (i.e. RR intervals) are usually examined in frequency domain analysis studies, it is assumed that during sinus rhythm the variability of heart rate is determined by changes in autonomic input to the sino-atrial node (i.e. it is assumed that variations in the AV interval do not significantly influence total heart rate variation). Studies on heart rate variability in settings outside of sinus rhythm are sparse, but occasional studies during atrial tachycardia(15) and atrial fibrillation (AF)(34, 35) have been performed. These utilized analysis of RR interval data, which represents a potential significant weakness.(8) During AF rhythmic fluctuations in RR intervals are potentially determined by both AV-nodal conduction and atrial input frequency.(23) Thus, spectral analysis of RR intervals during AF cannot be assumed to reflect solely or predominantly atrial events as it may be primarily determined by AV nodal factors.
This study set out to explore whether in patients with atrial fibrillation, vagal induced changes in atrial electrophysiology can be detected during rhythm-controlled respiration. This is a time frame much shorter than previously examined for autonomic influences on refractoriness. We utilized time-frequency analysis, (14, 16, 24, 27, 32) 
METHODS

Study population
Patients with permanent AF and complete heart block treated by permanent pacemaker were recruited. Exclusion criteria were pharmacological treatment with sympathomimetic or anticholinergic drugs, AF duration exceeding three years, or clinical conditions that could affect the autonomic nervous system, such as diabetes, hyperthyroidism, alcohol abuse, smoking or recent cardiovascular or cerebrovascular events. All patients gave written informed consent; the study was approved by the local Ethics Committee and complied with the Declaration of Helsinki.
Study Protocol and Data Acquisition
In line with recommended practice for autonomic studies, all studies were performed during the morning and patients were instructed to abstain from eating for four hours and from caffeine for 24 hours prior to commencing the study. Cardiovascular drugs, other than direct sympathomimetic or anti-cholinergic drugs, were not discontinued. On arrival the patients' pacemakers were programmed to pace at 60 bpm in unipolar VOO mode for the duration of the study.
Following the attachment of ECG electrodes and other preparation, patients were rested supine for 15 minutes in a quiet, temperature-controlled room. Electrocardiogram acquisition was then begun, and five minutes of baseline data was acquired. Subsequently, controlled respiration with four seconds inspiratory and four seconds expiratory phase duration was begun using auditory guidance (i.e. eight second cycles, respiratory frequency = 0.125 Hz) and a second five-minute period of data for analysis was acquired once the patient was in a stable synchronized respiratory pattern. Finally full vagal blockade was induced by intravenous administration of atropine (0.02 mg/kg). After a five minute interval, 0.125 Hz controlled respiration was again commenced and a final five-minute period of ECG for analysis was acquired. Real time ECG was monitored throughout the study and blood pressure was manually measured every minute.
Data Analysis (A) ECG ACQUISITION
A standard 12-lead ECG was acquired using a custom made optically isolated PC card (Siemens Elema AB, Solna, Sweden). The digital signal (1 kHz sampling rate, 16 bit analogue-to-digital conversion, 0.6 µV amplitude resolution) was transferred to a personal computer, where the data was written to a file for subsequent off-line processing. Electrocardiogram signal acquisition was continuous throughout the study, but the periods for subsequent analysis were noted at the time of recording.
(B) PACING SPIKE AND QRST REMOVAL
The initial stage comprised identification and digital subtraction of the unipolar pacing spike.
Subsequently QRST cancellation was performed using a spatiotemporal approach(33) which involves multiple templates, allowing an improved matching to each individual complex and leaving less ventricular residua than conventional processing.
In this study, only data from lead V1 was used for further analysis, although V2 and V3 data were used in the QRST cancellation process. Figure 1d . The frequency estimation was performed by aligning the spectrum of each new signal segment to a template spectrum with known main peak position. The advantage with such a procedure is that the entire energy of the signal (both fundamental frequency and harmonic pattern representing the rate and waveform shape of the signal, respectively) is used to obtain detailed frequency estimation. Estimation accuracy was ensured by requiring that both the peak magnitude and the ratio of the peak magnitude to the noise level of the spectrum exceeded certain thresholds. For each new spectrum, a template spectrum was formed by averaging frequency-aligned versions of previous spectra. All frequency estimates were used to provide a time series (see the frequency trend in Figure 1e ) for a second spectral analysis using the fast Fourier transform (FFT) to detect fluctuations of the peak frequency value within the band 0.04-0.4 Hz see Figure 1f for an example of such modulation spectra. This range was chosen such that it corresponds to the range of the conventionally tested high and low frequency bands (HF, 0.15 0.4 Hz and LF, 0.04 0.15 Hz respectively) examined in heart rate variability studies, and contains the frequency of interest (0.125 Hz). The spectra were estimated from segments of five minute duration from each of the three intervals of interest for analysis, namely, the initial period of quiet rest, baseline (B), the period of controlled respiration (CR) and, finally, the period of controlled respiration post-atropine administration (PA). Figure 1 illustrates the process from ECG via 'residual ECG' to final spectral analyses. 
Post-Processing Analyses and Statistics
RESULTS
Study Population
Eight patients (four female, median age 63 years, range 53 to 68) were included. Four patients were taking RAAS-inhibitors, one patient each was taking a β-blocker and a calcium channel antagonist, two patients were not using any heart active drug. Echocardiography demonstrated a median left atrial diameter of 42 mm (32 to 53) and a median ejection fraction of 55 % (35 to 55). The median AF duration was 17 months (range five to 32 months, defined as the elapsed time since last documented SR) and the patients had undergone a median of nine prior cardioversions (range 4 to 26) ( Table 1) .
Data Availability
All patients were able to satisfactorily perform the rhythm-controlled respiration and all provided recordings were suitable for analysis.
Population Observations
The median FF of patients at baseline was 6.9 Hz (6.1 to 8. Inspection of full spectra demonstrated that there was considerable but variable leakage of low frequency noise into the region of interest. To correct for the significant variability in total spectral power, the data were modeled by normalizing for this value. The resultant trends were similar ( Table 2 ). The ratio of P 0.125 to 'high frequency power' (0.15 -0.4 Hz) (P 0.125 /P HF ) was found to best reflect actual shifts in power and also corrected for the absolute pollution of the spectrum. P 0.125 /P HF rose significantly during controlled respiration from 1.4 (0.76 to 2.0) at baseline to 2.7 (1.2 to 5.8) (p = 0.01) and fell to 1.2 (0.23 to 2.8) (p = 0.01) following atropine administration (figure 2). There was no significant difference between the baseline and postatropine P 0.125 /P HF (p = 0.40). There were no significant changes in other measured parameters.
Observations in Individual Patients
The response to controlled respiration was heterogeneous. Although all patients increased the P 0.125 /P HF during controlled respiration followed by a decrease after vagal blockade, the amount of response was variable (table 3) . A spectrum from a single patient is illustrated in figure 3 . In this patient, and in some but not all of the other patients, there appears to be significant low frequency spectral power exhibited in the low frequency band. Some of this energy might represent artifacts, but at present quantification of absolute power in both the low and high frequency band, as can be done during sinus rhythm, is not validated. No differences in patient characteristics in terms of age, AF-duration, LA-diameter, previous cardioversions, heart-drugs and other diseases could be found between marked responders and the less responsive patients. While enhanced parasympathetic tone prolongs the ventricular refractory period (17) it has the opposite affect in the atria during sinus rhythm. (17, 21, 31) The effect on atrial myocardium during AF is less studied but the evidence that exists, suggest that acetylcholine and enhanced vagal tone shortens the effective refractory period(16, 34) as it does during sinus rhythm.
DISCUSSION
Consequently, enhanced vagal tone would lead to a higher fibrillation frequency, this could however not be verified in this study.
The response of vagal discharge is believed to be inhomogeneous, as the right atrium has more extensive parasympathetic innervation than the left atrium. 
Mechanism of Shift in Spectral Power in Response to Slow Controlled Respiration and
Attenuation by Atropine
Physiologically the atrial refractory period adapts automatically to changes in heart rate (i.e. depolarization rate). These changes occur immediately. 
Preserved Dynamic Electrophysiological Changes in Chronic AF and Possible
Mechanisms for Inter-Patient Variability
Two very interesting aspects of the present study are firstly the fact that dynamic changes in atrial fibrillatory rhythm were detectable among patients with long duration AF, and secondly the observed inter-patient variation. All patients had long duration of AF and thus by current understanding, electrical remodeling would be expected to be 'complete'.(4, 13) The degree of spectral power shift to 0.125 Hz with controlled respiration was variable.
Previous studies have shown that following pharmacological interventions (and autonomic modulation) the change in FF is more pronounced in those who have a lower initial value.(24, 25) This implies that the atrium is only susceptible to modulation if the FF is low. However there was no such trend seen in the present study.
The present study is too small and the population too heterogeneous to draw conclusions regarding the importance of the above factors, but the variable preservation of responsiveness to autonomic stimuli is an important observation.
Methodological issues and Study limitations
Although all patients had long duration AF and complete heart block, the population was heterogeneous in ways which may be relevant. Complete heart block and AF are associated with, or directly caused by, a range of conditions such as congestive heart failure, other heart diseases, and with advanced age. All of these conditions are associated with attenuation of parasympathetic tone(10) and some of which were present in our patients. Conversely, half the patients in our study were taking RAAS inhibitors, and blockade of the renin-angiotensin system is known to increase the activity in the low-frequency band and to decrease the fluctuations at respiratory frequencies.(1, 2) One patient was taking a beta-blocker, which has been shown to shift the frequency distribution towards higher frequencies,(9) although the exact effects are complex the shift may be induced by augmentation of vagal tone.
We excluded conditions and drugs which might have abolished autonomic modulations, but this compromise was made for logistical (patient recruitment) and ethical reasons (inadvisability of drug withdrawal in elderly patients with cardiac co-morbidity and without gain from participation in our study).
In this study we estimated changes in atrial FF using time-frequency analysis, which is an indirect assessment of atrial refractoriness. This method cannot discriminate between changes in atrial refractoriness and conduction velocity; the latter, however, is unlikely to change after atropine administration. The response of conduction velocity to controlled, slow respiration is uncertain, but since atropine attenuated the induced change (it is assumed that atropine does not affect the conduction velocity), it is likely that the observed change in atrial refractoriness is genuine.
Time-frequency analysis from the V1 lead correlates to the fibrillatory cycle length of the right atrial free wall, and therefore direct deductions about the rest of the atria can not be made.
Equally, this study recruited patients with longstanding AF. Therefore inferences about shorter duration AF can not be made, although it would be expected that the dynamic responsiveness of less re-modeled atria would be more pronounced.
The respiration was controlled by the use of auditory guidance but the definite respiration frequency was not objectively assessed during the study. Therefore it is possible that the full extent of the parasympathetic modulation of FF via respiration may be larger than found in the present study.
Conclusions
We found that slow controlled respiration causes cyclic alterations of AF rhythm at the respiratory frequency in patients with long lasting AF. The attenuation of this phenomenon by vagal blockade confirms that the observation is genuinely related to parasympathetic modulations of atrial electrophysiology. Our utilization of paced patients with complete heart block excludes any mechanism related to autonomic effects on the atrioventricular node and the cancellation of ventricular components of the ECG out-rules contributions of ventricular depolarization to the spectral analysis. All values represent the absolute values of power calculated at the frequency of respiration divided by the mean power value in the high frequency band (P 0.125 /P HF ). 
